The firm returning 200% since IPO
After an earlier downturn in listings, initial public offerings (IPOs) have picked up in the second half of the year with a total of 56 expected by year end, with one IPO returning 200% since its listing.
There were only 12 companies which listed on the Australian Securities Exchange (ASX) during the first half of 2020 but there had been double that number since 1 July to the end of October with 24 companies listing during the period.
There were a further 20 expected to list by the end of the year which would take the 2020 total to 56, not far off the 63 companies listed in 2019.
The companies which listed in the first half of the year were Nyrada Inc, Happy Valley Nutrition, Cosol, Cobre, Emerald Clinics, Thedocyard, Castile Resources, Little Green Pharma, Kaiser Reef, Atomo Diagnostics, AML3D, and Intelicare.
Since 1 July to 10 November, the best-performing stock over the period was AML3D, which returned 200%, significantly better than the second-best performer, Castile Resources, which returned 77%.
When factoring when it had listed, AML3D, a 3D metal printing business founded in 2014, had returned 200% since its 20 April listing compared to returns of 20% by the ASX 200.
However, there were three companies which had both lost money and underperformed the ASX 200. These were Cobre which lost 11%, Intelicare which lost 22.7% and Happy Valley which lost 28.5%, compared to positive returns by the ASX 200 of 7.8%.
According to Vanguard, less than 20% of Australian IPOs this year were trading above their opening day closing price and more than 40% were trading below their initial offer price. Others had failed to outpace returns by the wider index.
It was believed the IPO boom was being driven by speculators who were seeking short-term profits in the face of low interest rates. Rates were cut by the Reserve Bank of Australia to 0.1% last week which meant cash returns were negative after inflation.
This was evidenced by the number of investors who were buying into companies during the initial offer process and then selling out very quickly once they had listed.
AUTHOR
Laura Dew
Recommended for you
Lonsec and SQM Research have highlighted manager selection as a crucial risk for financial advisers when it comes to private market investments, particularly due to the clear performance dispersion.
Macquarie Asset Management has indicated its desire to commit the fast-growing wealth business in Australia by divesting part of its public investment business to Japanese investment bank Nomura.
Australia’s “sophisticated” financial services industry is a magnet for offshore fund managers, according to a global firm.
The latest Morningstar asset manager survey believes ETF providers are likely to retain the market share they have gained from active managers.
